Role of autacoids in cardiovascular collapse in anaphylactic shock in anesthetized dogs

Cardiovascular Research

Volumn 43, Issue 1, 1999, Pages 173-182

  Mink, S ^a   Becker, A ^a   Sharma, S ^a   Unruh, H ^a   Duke, K ^a   Kepron, W ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Hemodynamics; Immunology; Pathophysiology; Prostaglandins; Pulm onary circulation; Shock; Vasculature

Indexed keywords

HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTAMINE H3 RECEPTOR ANTAGONIST; LEUKOTRIENE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; THIOPERAMIDE; THROMBOXANE;

ANAPHYLACTIC SHOCK; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOGENIC SHOCK; CONTROLLED STUDY; CORONARY HEMODYNAMICS; DOG; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; INTRAVENOUS DRUG ADMINISTRATION; LUNG WEDGE PRESSURE; MEAN ARTERIAL PRESSURE; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; SYSTEMIC VASCULAR RESISTANCE;

ANALYSIS OF VARIANCE; ANAPHYLAXIS; ANIMALS; CARDIOVASCULAR SYSTEM; CYCLOOXYGENASE INHIBITORS; DOGS; HEMODYNAMIC PROCESSES; HISTAMINE ANTAGONISTS; HISTAMINE H1 ANTAGONISTS; HISTAMINE H2 ANTAGONISTS; INDOLES; INDOMETHACIN; INFLAMMATION MEDIATORS; LIPOXYGENASE INHIBITORS; PIPERIDINES; QUINOLINES; RANDOM ALLOCATION; RANITIDINE; RECEPTORS, HISTAMINE H3;

EID: 0032994784     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00073-5     Document Type: Article

References (40)

1. Wasserman S. The heart in anaphylaxis. J Allergy Clin Immunol. 77:1986;663-666.
2. Yunginger J.W. Anaphylaxis. Ann Allergy. 69:1992;87-96.
3. Haupt M., Carlson R.W. Anaphylaxis. Carlson R.W., Gehed M.A. Principles and Practice of Medical Intensive Care. 1987;1650-1659 WB Saunders, Philadelphia.
4. 4: Effects on human and guinea-pig cardiac preparations in vitro. J Pharmacol Exp Ther. 221:1982;235-241.
5. 2 effects. Basic Res Cardiol. 83:1988;531-539.
6. Serafin W.E., Babe K.S. Autacoids: drug therapy of inflammation. Hardman J., Limbird L. Goodman and Gilman's, The Pharmacological Basis of Therapeutics. 9th ed :1996;579-580 McGraw-Hill, New York.
7. 3 receptor signaling in the heart: possible involvement of Gi/Go proteins and N-Type Ca channels. J Pharmacol Exp Ther. 269:1994;221-229.
8. Guo Z.-G., Levi R., Graver L., Robertson D., Gay W. Inotropic effects of histamine in human myocardium: differentiation between positive and negative components. J Cardiovascular Pharm. 6:1984;1210-1215.
9. 3 receptor mediated decrease in basal vascular resistance in guinea-pigs. Br J Pharmacol. 110:1993;553-558.
10. McNeil J. Histamine and the heart. Can J Physiol Pharmacol. 62:1984;720-726.
11. 2 receptors in pulmonary and systemic vasculature of the dog. Am J Physiol. 229:1975;1008-1013.
12. Campbell W., Halushka P. Lipid derived autacoids: Eicosanoids and platelet activating factor. Hardman J., Limbird L. Goodman and Gilman's, The Pharmacological Basis of Therapeutics. 9th ed :1996;601-616 McGraw-Hill, New York.
13. Hintze T., Kaley G. Prostaglandins and the control of blood flow in the canine myocardium. Circ Res. 40:1977;313-320.
14. Nutter D., Crumly H. Canine coronary vascular and cardiac responses to the prostaglandins. Cardiovasc Res. 6:1972;217-225.
15. Levi R., Burke J., Guo Z., et al. Acetyl glyceryl ether phosphorylcholine: a putative mediator of cardiac anaphylaxis in the guinea pig. Circ Res. 54:1984;117-124.
16. Frey M.J., Chestown S.E., Reed B.R., et al. Immunologic release of histamine from dog lung: comparison of in vivo and in vitro responses in the same animal. J Allergy Clin Immunol. 74:1984;728-729.
17. Silverman H., Taylor W., Smith P., et al. Effect of antihistamines on the cardiopulmonary changes due to canine anaphylaxis. J Appl Physiol. 64:1988;210-217.
18. Correa E., Mink S., Unruh H., Kepron W. Left ventricular contractility is depressed in IgE-mediated anaphylactic shock in dogs. Am J Physiol. (Heart Circ Physiol 29). 260:1991;H744-H751.
19. 2 receptor blockade in a canine model of ragweed hypersensitivity. Am J Respir Dis. 131:1985;386A.
20. Kepron W., James J., Kirk B., Sehon A., Tse K. A canine model for reaginic hypersensitivity and allergic bronchoconstriction. J Allergy Clin Immunol. 59:1977;64-69.
21. Mink S.N., Becker A., Unruh H., Kepron W. Effects of anaphylaxis mediators on partitioned pulmonary vascular resistance during ragweed shock in dogs. J Appl Physiol. 84:1998;782-790.
22. Hanly P., Sienko A., Light R.B. Effect of cyclooxygenase blockade on gas exchange and hemodynamics in Pseudomonas pneumonia. J Appl Physiol. 63:1987;1829-1836.
23. Brideau C., Chan C., Charleson S., et al. Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)-indol-2-yl]-2, 2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitor. Can J Physiol Pharmacol. 70:1992;799-807.
24. Frederiksen M., Henthorn T., Ruo T., Atkinson A. Pharmacokinetics of pentobarbital in dogs. J Pharmacol Exp Ther. 225:1983;355-360.
25. Unruh H., Wang R., Bose D., Mink S. Does pentobarbital anaesthesia depress left ventricular contractility in dogs? Am J Physiol (Heart Circ Physiol 30). 261:1991;H700-H706.
26. Mink S.N., Light R.B., Cooligan T., Wood L.D.H. Effect of PEEP on gas exchange and pulmonary perfusion in canine lobar pneumonia. J Appl Physiol. 50:1981;517-523.
27. Morel A., Delaage M. Immunoanalysis of histamine through a novel chemical derivatization. J Allergy Clin Immunol. 82:1988;646-654.
28. Heavey D., Soberman R., Lewis R., Spur B., Austen F. Critical considerations in the development of an assay for sulfidopeptide leukotrienes in plasma. Prostaglandins. 5:1987;693-706.
29. Snedecor G.W., Cochran W.G. Statistical methods. 6th ed :1967;271-275 Iowa State University Press.
30. 2 receptor antagonism on the response of monkey skin to intradermal histamine, reverse-type anaphylaxis, and passive cutaneous anaphylaxis. J Allergy Clin Immunol. 63:1979;376-382.
31. 2 antihistamines on allergic histamine release and its inhibition by histamine. J Pharmacol Exp Ther. 192:1975;441-449.
32. Ting S., Rauls D., Reiman B. Inhibitory effect of hydroxyzine on antigen-induced histamine release in vivo. J Allergy Clin Immunol. 75:1985;63-66.
33. Liebig R., Bernauer W., Peskar B. Prostaglandin, slow-reacting substance, and histamine release from anaphylactic guinea-pig hearts, and its pharmacological modification. Naunyn-Schmiedeberg's Arch. Pharmacol. 289:1975;65-76.
34. Kleeberger S.R., Kolbe J., Adkinson N.F., Peters S.P., Spannhake E.W. Central role of cyclooxygenase in the response of canine peripheral airways to antigen. J Appl Physiol. 61:1986;1309-1315.
35. Fink M.P., MacVittie T.J., Casey L.C. Inhibition of prostaglandin synthesis restores normal hemodynamics in canine hyperdynamic sepsis. Ann Surg. 200:1984;619-626.
36. Hales C.A., Rouse E.T., Slate J.L. Influence of aspirin and indomethacin on variability of alveolar hypoxic vasoconstriction. J Appl Physiol. 45:1978;33-39.
37. Wagner E.M., Mitzner W.A., Bleeker E.R. Peripheral circulatory alterations in canine anaphylactic shock. Am J Physiol. 251:1986;H934-H940.
38. Cox R. Influence of pentobarbital anesthesia on cardiovascular function in trained dogs. Am J Physiol. 223:1972;651-659.
39. Manders W., Vatner S. Effects of sodium pentobarbital anesthesia on left ventricular function and distribution of cardiac output in dogs with particular reference to the mechanism of tachycardia. Circ Res. 39:1976;512-517.
40. Smith P.L., Kagey-Sobotka A., Bleecker E.R., et al. Physiologic manifestations of human anaphylaxis. J Clin Invest. 66:1980;1072-1080.